Millions around the world face the daily challenges of Type 1 Diabetes (T1D), an autoimmune disease that disrupts the body's ability to produce insulin. As part of our commitment to creating groundbreaking treatments for chronic illnesses, Rise Therapeutics and Spectrum Clinical Research are supporting the effort to cure, prevent, and treat T1D.
JDRF OneWalk: Strides Towards a Brighter Future
JDRF OneWalk is a signature fundraising event organized by the JDRF (Juvenile Diabetes Research Foundation). It's a community event where people of all ages and backgrounds come together to walk, raise awareness, and crucially, fund critical research for T1D.
Rise Therapeutics and Spectrum Clinical Research are joining forces as a team for the JDRF OneWalk. We believe in the power of collaboration and are committed to supporting this impactful event. With a committed booth, our team was engaged with the public and spread the word about our love of making people's lives better. We had diabetes snacks, treats and easy to eat for kids and educational information about our current research projects.
Our team Spectrum Clinical Research and Rise Therapeutics shared information to the community in the Los Angeles area regarding current T1D clinical trial for adolescent (11-17) recently diagnosed and can stay on their current medication including daily insulin injection American Diabetes Association.
T1D research thrives on collective action. By participating in the JDRF OneWalk, we can show our support for the millions living with T1D and contribute to the ongoing search for a cure.
Together, we can walk a little further, raise a little more, and bring us a step closer to a future free from T1D.
Register for the JDRF OneWalk: Visit the JDRF website (https://www2.jdrf.org/site/SPageServer?pagename=about_walk) to find a walk near you and register to participate.
Millions around the world face the daily challenges of Type 1 Diabetes (T1D), an autoimmune disease that disrupts the body's ability to produce insulin. As part of our commitment to creating groundbreaking treatments for chronic illnesses, Rise Therapeutics and Spectrum Clinical Research are supporting the effort to cure, prevent, and treat T1D.
JDRF OneWalk: Strides Towards a Brighter Future
JDRF OneWalk is a signature fundraising event organized by the JDRF (Juvenile Diabetes Research Foundation). It's a community event where people of all ages and backgrounds come together to walk, raise awareness, and crucially, fund critical research for T1D.
Rise Therapeutics and Spectrum Clinical Research are joining forces as a team for the JDRF OneWalk. We believe in the power of collaboration and are committed to supporting this impactful event. With a committed booth, our team was engaged with the public and spread the word about our love of making people's lives better. We had diabetes snacks, treats and easy to eat for kids and educational information about our current research projects.
Our team Spectrum Clinical Research and Rise Therapeutics shared information to the community in the Los Angeles area regarding current T1D clinical trial for adolescent (11-17) recently diagnosed and can stay on their current medication including daily insulin injection American Diabetes Association.
T1D research thrives on collective action. By participating in the JDRF OneWalk, we can show our support for the millions living with T1D and contribute to the ongoing search for a cure.
Together, we can walk a little further, raise a little more, and bring us a step closer to a future free from T1D.
Register for the JDRF OneWalk: Visit the JDRF website (https://www2.jdrf.org/site/SPageServer?pagename=about_walk) to find a walk near you and register to participate.
2700 Clay Edwards Dr,
Suite 260,
North Kansas City, MO 64116
8105 North Oak Trafficway,
Kansas City, MO 64118
Monday
9:00 am - 5:00 pm
Tuesday
9:00 am - 5:00 pm
Wednesday
9:00 am - 5:00 pm
Thursday
9:00 am - 5:00 pm
Friday
9:00 am - 5:00 pm
Saturday
Closed
Sunday
Closed